BeOne Medicines Ltd.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONC and other ETFs, options, and stocks.About ONC
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations.
CEOJohn V. Oyler
CEOJohn V. Oyler
Employees12,000
Employees12,000
HeadquartersBasel, Basel-Landschaft (Basle Country)
HeadquartersBasel, Basel-Landschaft (Basle Country)
Founded2010
Founded2010
Employees12,000
Employees12,000
ONC Key Statistics
Market cap37.45B
Market cap37.45B
Price-Earnings ratio113.31
Price-Earnings ratio113.31
Dividend yield—
Dividend yield—
Average volume236.49K
Average volume236.49K
High today$289.88
High today$289.88
Low today$281.04
Low today$281.04
Open price$286.54
Open price$286.54
Volume257.55K
Volume257.55K
52 Week high$385.22
52 Week high$385.22
52 Week low$196.45
52 Week low$196.45
ONC News
TipRanks 2d
Early Cancer Drug Trial Termination Highlights Pipeline Risk for BeOne MedicinesBeOne Medicines (ONC) announced an update on their ongoing clinical study. BeOne Medicines has reported a key update on a BeiGene-sponsored early cancer trial,...
Analyst ratings
96%
of 26 ratingsBuy
96.2%
Hold
3.8%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.